The trademark application AMPCASUS was filed by Celgene Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 10, 2022, and it was registered by office on June 17, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).